Fig. 4 (abstract P579).
From: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
Chemerin treatment comp PD-L1 siRNA & atezolizumab
Fig. 4 (abstract P579). | Journal for ImmunoTherapy of Cancer